BFM
Boothbay Fund Management’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-493,311
| Closed | -$5.52M | – | 1377 |
|
|
2024
Q2 | $5.52M | Sell |
493,311
-293,496
| -37% | -$3.28M | 0.13% | 166 |
|
|
2024
Q1 | $5.19M | Sell |
786,807
-302,899
| -28% | -$2M | 0.1% | 179 |
|
|
2023
Q4 | $4.93M | Buy |
1,089,706
+44,494
| +4% | +$201K | 0.13% | 161 |
|
|
2023
Q3 | $3.74M | Buy |
1,045,212
+31,375
| +3% | +$112K | 0.09% | 247 |
|
|
2023
Q2 | $3.74M | Sell |
1,013,837
-220,667
| -18% | -$814K | 0.08% | 259 |
|
|
2023
Q1 | $4.09M | Buy |
1,234,504
+183,119
| +17% | +$606K | 0.08% | 270 |
|
|
2022
Q4 | $4.08M | Sell |
1,051,385
-7,069,768
| -87% | -$27.4M | 0.09% | 236 |
|
|
2022
Q3 | $19.7M | Sell |
8,121,153
-2,239,247
| -22% | -$5.44M | 0.49% | 6 |
|
|
2022
Q2 | $20.5M | Sell |
10,360,400
-47,859
| -0.5% | -$94.8K | 0.54% | 4 |
|
|
2022
Q1 | $19M | Buy |
10,408,259
+2,124,399
| +26% | +$3.89M | 0.44% | 12 |
|
|
2021
Q4 | $11.7M | Buy |
8,283,860
+5,153,324
| +165% | +$7.27M | 0.27% | 37 |
|
|
2021
Q3 | $3.54M | Buy |
3,130,536
+2,903,067
| +1,276% | +$3.28M | 0.1% | 193 |
|
|
2021
Q2 | $364K | Buy |
227,469
+24,385
| +12% | +$39K | 0.01% | 1023 |
|
|
2021
Q1 | $357K | Buy |
203,084
+59,549
| +41% | +$105K | 0.01% | 910 |
|
|
2020
Q4 | $280K | Buy |
143,535
+53,453
| +59% | +$104K | 0.01% | 822 |
|
|
2020
Q3 | $215K | Buy |
90,082
+1,582
| +2% | +$3.78K | 0.01% | 804 |
|
|
2020
Q2 | $259K | Sell |
88,500
-62,243
| -41% | -$182K | 0.02% | 621 |
|
|
2020
Q1 | $434K | Buy |
+150,743
| New | +$434K | 0.04% | 407 |
|